Mon panier

Biotinylated Human TNF-alpha Protein, Fc,Avitag™ (MALS verified)

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
TNA-H82F3-25ug
$380.00
TNA-H82F3-200ug
$1645.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Synonyms

    DIF, TNF-alpha, TNFA, TNFSF2, cachexin, cachectin, TNFα

  • Source

    Biotinylated Human TNF-alpha Protein, Fc,Avitag (TNA-H82F3) is expressed from human 293 cells (HEK293). It contains AA Val 77 - Leu 233 (Accession # P01375-1).

    Predicted N-terminus: Val 77

    Request for sequence
  • Molecular Characterization

    TNF-alpha Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a human IgG1 Fc tag at the C-terminus, followed by an Avi tag (Avitag™).

    The protein has a calculated MW of 45.5 kDa. The protein migrates as 50-55 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Labeling

    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

  • Protein Ratio

    Passed as determined by the HABA assay / binding ELISA.

  • Purity

    >90% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • SDS-PAGE

    TNF-alpha SDS-PAGE

    Biotinylated Human TNF-alpha Protein, Fc,Avitag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    TNF-alpha SEC-MALS

    The purity of Biotinylated Human TNF-alpha Protein, Fc,Avitag (Cat. No. TNA-H82F3) is more than 85% and the molecular weight of this protein is around 275-315 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     TNF-alpha ELISA

    Immobilized Human TNFR1, Fc Tag (Cat. No. TN1-H5251) at 5 μg/mL (100 μL/well) can bind Biotinylated Human TNF-alpha Protein, Fc,Avitag (Cat. No. TNA-H82F3) with a linear range of 0.1-3 ng/mL (QC tested).

    Protocol
  •  TNF-alpha ELISA

    Immobilized Human TNFR2, His Tag (Cat. No. TN2-H5227) at 5 μg/mL (100 μL/well) can bind Biotinylated Human TNF-alpha Protein, Fc,Avitag (Cat. No. TNA-H82F3) with a linear range of 0.1-6 ng/mL (Routinely tested).

    Protocol
  •  TNF-alpha ELISA

    Immobilized Humira at 1 μg/mL (100 μL/well) can bind Biotinylated Human TNF-alpha Protein, Fc,Avitag (Cat. No. TNA-H82F3) with a linear range of 0.1-6 ng/mL (Routinely tested).

    Protocol

Avis des utilisateurs
Publier un commentaire

Introduction de fond

Tumor necrosis factor alpha (TNFα) is a cytokine produced primarily by monocytes and macrophages. It is found in synovial cells and macrophages in the tissues.The primary role of TNFα is in the regulation of immune cells. TNFα is able to induce apoptotic cell death, to induce inflammation, and to inhibit tumorigenesis and viral replication. Dysregulation of TNFα production has been implicated in a variety of human diseases, including major depression, Alzheimer's disease and cancer. Recombinant TNFα is used as an immunostimulant under the INN tasonermin. TNFα can be produced ectopically in the setting of malignancy and parallels parathyroid hormone both in causing secondary hypercalcemia and in the cancers with which excessive production is associated.

Progrès de frontière

 
Progrès du développement médicamenteux
  • Nom anglais:

    Tumor necrosis factor α

  • Catégorie:

  • Nombre de médicaments répertoriés:

    68 Détails

  • Nombre de médicaments cliniques:

    74 Détails

  • Étape de développement la plus élevée:

    Approved

Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs
  • Contexte